Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antagonist activity at NOD2 in human HEK-Blue hNOD2 cells assessed as inhibition of MDP-induced NOD2 activation
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of TNF-alpha production at 1 uM incubated for 18 hrs in presence of LPS
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of IL-6 production at 1 uM incubated for 18 hrs in presence of LPS
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of IL-1beta production at 1 uM incubated for 18 hrs in presence of LPS
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of IL-8 production at 1 uM incubated for 18 hrs in presence of IFN-gamma
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of TNFalpha production at 1 uM incubated for 18 hrs in presence of IFN-gamma
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of IL-6 production at 1 uM incubated for 18 hrs in presence of IFN-gamma
Synergistic agonist activity at NOD2 in human PBMC assessed as induction of IL-1beta production at 1 uM incubated for 18 hrs in presence of IFN-gamma
Agonist activity at NOD2 in human PBMC assessed as induction of TNFalpha production at 1 uM incubated for 18 hrs pretreated with NOD2 antagonist
Agonist activity at NOD2 in human PBMC assessed as induction of IL-6 production at 1 uM incubated for 18 hrs pretreated with NOD2 antagonist
Agonist activity at NOD2 in human PBMC assessed as induction of IL-1beta production at 1 uM incubated for 18 hrs pretreated with NOD2 antagonist
Agonist activity at NOD2 in human PBMC assessed as induction of IL-8 production at 1 uM incubated for 18 hrs pretreated with NOD2 antagonist
Agonist activity at NOD2 in human PBMC assessed as induction of TNFalpha production at 1 uM incubated for 18 hrs
Assay data:3 Active, 3 Tested
Agonist activity at NOD2 in human PBMC assessed as induction of IL-8 production at 1 uM incubated for 18 hrs
Agonist activity at NOD2 in human PBMC assessed as induction of IL-6 production at 1 uM incubated for 18 hrs
Agonist activity at NOD2 in human PBMC assessed as induction of IL-1beta production at 1 uM incubated for 18 hrs
Agonist activity at human human NOD2 expressed in HEK-Blue NOD2 reporter cells in presence of NOD2 antagonist by colorimetry based SEAP assay
Assay data:27 Tested
Agonist activity at human human NOD2 expressed in HEK-Blue NOD2 reporter cells by colorimetry based SEAP assay
Assay data:24 Active, 17 Activity ≤ 1 µM, 27 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Agonist activity at NOD2 in HEK-Blue hNOD2 cells assessed as increase in SEAP activity at 20 ug incubated for 24 hrs by Quanti-blue assay
Assay data:6 Active, 6 Tested
Agonist activity at NOD2 in HEK-Blue hNOD2 cells assessed as increase in NFkappaB activation at 10 uM incubated for 18 hrs by SEAP-based spectrophotometry analysis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on